MD Anderson and Boehringer Ingelheim to Partner on Cancer, Found a Virtual R&D Center

Ingelheim, Germany-based Boehringer Ingelheim and Houston-based The University of Texas MD Anderson Cancer Center announced a multi-year deal to research advanced therapies for cancers, including gastrointestinal and lung cancers. They will found a joint Virtual Research and Development Center to allow data sharing and analysis.